Equita Capital SGR, a multi-asset manager of Equita Group, agreed to acquire Clonit, an Italian companies operating in the field of biotechnology. Financial terms were not disclosed. “We are very satisfied with this first investment because Clonit well represents our ideal target, in terms of size, industrial sector to which it belongs, growth opportunities and resilience capacity. Our primary objective is to support the founding members and equip the Company with all the technical skills and financial resources necessary to carry out the ambitious development plan and thus seize all the growth opportunities offered by the market ," Rossano Rufini, Equita Capital SGR Managing Partner.